State officials announced a plan to support the building of a new, state-of-the-art facility in Chesterfield by Pfizer Inc., one of the world’s premier biopharmaceutical companies. Pfizer has been in Missouri for more than 13 years and currently employs more than 450 scientists and other professionals in the state.
The company expects to create 80 new jobs through the Chesterfield project over the next few years. To support Pfizer’s new facility, the state has offered a strategic economic incentive package that the company can receive if it meets strict job creation criteria. The expansion is also being made possible through local incentives offered by St. Louis County.
Construction of the $200 million facility is expected to begin in mid-2017 and be completed by 2020. St. Louis-based Clayco will be the lead developer and owner of the new facility in Chesterfield.
Gov. Jay Nixon said Pfizer will benefit from the educated talent pool Missouri offers.
“Companies like Pfizer benefit from this growing talent pool and the natural synergy that comes with being part of the region’s burgeoning bioscience community,” he said. “Our education and research institutions are shaping the brightest minds that are eager to get into the lab and make a difference in the world.”
Over the past few years, Missouri’s position as the center for bioscience and biotechnology has been bolstered through several major announcements of new jobs and investments. The state also has garnered expansions from several foreign bioscience companies that are setting up headquarters and labs right here in the Show-Me State for the first time.
To read the full release, click here.